Based on the fundamental research performed by Tumeh et al. [46], investigating the CD8+ T-cell infiltration in melanoma patients receiving immunotherapy through serial biopsies, we extrapolated the difference in T-cell abundance between responding and non-responding patients to estimate the required cell labelling efficiency needed for detection through XFI. The gene discussed is CD8A; the disease is melanoma.